You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
复宏汉霖-B(02696.HK):委任张文杰为首席执行官,持续推动创新与国际化战略布局
格隆汇 09-30 16:59

格隆汇9月30日丨复宏汉霖-B(02696.HK)公布,ScottShi-Kau Liu博士因个人工作重心调整的原因已呈请辞任公司执行董事、董事会战略委员会委员、环境、社会及管治委员会委员及公司首席执行官,自2020年9月30日起生效。辞任后LIU博士将担任公司的战略咨询委员会主任,关注公司研发方向、公司战略的制定以及团队建设和发展。

张文杰先生已获提名出任第二届董事会执行董事,待公司股东于临时股东大会上批准后,方可作实,并自2020年9月30日起获委任为公司首席执行官。张先生作为公司首席执行官兼总裁将带领高级管理团队进行公司日常管理,并监督公司及其附属公司的营运。

张先生,52岁,自2019年3月至2020年2月担任公司高级副总裁、首席商业运营官及首席战略官,并自2020年2月起担任公司总裁、公司全资附属公司上海复宏汉霖生物制药有限公司总裁、上海复宏汉霖生物医药有限公司总裁,负责集团运营管理,着力搭建集团创新商业运营模式,打造国际化战略布局,并成功推动集团核心产品HLX02注射用曲妥珠单抗(中国境内商品名:汉曲优)的顺利上市。

张先生于医药行业拥有逾25年商业运营及管理经验。在加入公司之前,张先生曾担任安进中国的总经理、中国上海罗氏制药有限公司肿瘤业务二部副总裁、中国拜耳先灵特药及肿瘤部负责人等。张先生于1990年7月自中国山东大学获得微生物学学士学位,并于1998年5月自美国耶鲁大学获得工商管理硕士学位。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account